{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:55:43Z","timestamp":1715579743395},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,1,1]]},"DOI":"10.1038\/sj.jhh.1001297","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:38:32Z","timestamp":1031251112000},"page":"1-3","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sibutramine and blood pressure: a therapeutic dilemma"],"prefix":"10.1038","volume":"16","author":[{"given":"G A","family":"Bray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"BF1001297_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","volume":"22","author":"KM Flegal","year":"1998","unstructured":"Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL . Overweight and obesity in the United States: prevalence and trends, 1960\u20131994 Int J Obes 1998 22: 39\u201347","journal-title":"Int J Obes"},{"key":"BF1001297_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.jhh.1001299","volume":"16","author":"JJ Sramek","year":"2002","unstructured":"Sramek JJ et al. Efficacy and safety of sibutramine for weight loss in obesepatients with hypertension well controlled by \u03b2-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial J Hum Hypertens 2002 16: 13\u201319","journal-title":"J Hum Hypertens"},{"key":"BF1001297_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.jhh.1001298","volume":"16","author":"FG McMahon","year":"2002","unstructured":"McMahon FG et al. Sibutramine is safe and effective for weight loss in obesepatients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors J Hum Hypertens 2002 16: 5\u201311","journal-title":"J Hum Hypertens"},{"key":"BF1001297_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/eurheartj\/8.suppl_B.57","volume":"8 (Suppl B)","author":"S MacMahon","year":"1987","unstructured":"MacMahon S, Cutler J, Brittain E, Higgins M . Obesity and hypertension: epidemiological and clinical issues (Review) Eur Heart J 1987 8 (Suppl B): 57\u201370","journal-title":"Eur Heart J"},{"key":"BF1001297_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/1047-2797(91)90046-F","volume":"1","author":"JA Cutler","year":"1991","unstructured":"Cutler JA . Randomized clinical trials of weight reduction in nonhypertensive persons (Review) Ann Epidemiol 1991 1: 363\u2013370","journal-title":"Ann Epidemiol"},{"key":"BF1001297_CR6","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1001\/jama.1989.03430130077038","volume":"262","author":"R Stamler","year":"1987","unstructured":"Stamler R et al. Primary prevention of hypertension by nutritional-hygienic means JAMA 1987 262: 1801\u20131807","journal-title":"JAMA"},{"issue":"1","key":"BF1001297_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/archinte.1990.00390130131021","volume":"150","author":"Hypertension Prevention Trial Resea","year":"1990","unstructured":"The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure Hypertension Prevention Trial Research Group. Arch Intern Med 1990 150: 153\u2013162","journal-title":"Archives of Internal Medicine"},{"key":"BF1001297_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archinte.1993.00410070039006","volume":"153","author":"VJ Stevens","year":"1993","unstructured":"Stevens VJ et al. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group Arch Interm Med 1993 153: 849\u2013858","journal-title":"Arch Interm Med"},{"key":"BF1001297_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","volume":"134","author":"VJ Stevens","year":"2001","unstructured":"Stevens VJ et al. Trials for the Hypertension Prevention Research Group. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II Ann Intern Med 2001 134: 1\u201311","journal-title":"Ann Intern Med"},{"key":"BF1001297_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/j.1550-8528.1999.tb00436.x","volume":"7","author":"CD Sjostrom","year":"1999","unstructured":"Sjostrom CD, Lissner L, Wedel H, Sjostrom L . Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study Obes Res 1999 7: 477\u2013484","journal-title":"Obes Res"},{"key":"BF1001297_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA et al. Sibutramine produces dose-related weight loss Obes Res 1999 7: 189\u2013198","journal-title":"Obes Res"},{"key":"BF1001297_CR12","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WP James","year":"2000","unstructured":"James WP et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance Lancet 2000 356: 2119\u20132125","journal-title":"Lancet"},{"key":"BF1001297_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/sj.ijo.0801098","volume":"24","author":"G Fanghanel","year":"2000","unstructured":"Fanghanel G, Cortinas L, Sanchez-Reyez L, Berber A . A clinical trial of the use of sibutramine for the treatment ofpatients suffering essential obesity Intern J Obes 2000 24: 144\u2013150","journal-title":"Intern J Obes"},{"key":"BF1001297_CR14","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","volume":"160","author":"FG McMahon","year":"2000","unstructured":"McMahon FG et al. Efficacy and safety of sibutramine in obese white and African Americanpatients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial Arch Intern Med 2000 160: 2185\u20132191","journal-title":"Arch Intern Med"},{"key":"BF1001297_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","volume":"352","author":"L Sjostrom","year":"1998","unstructured":"Sjostrom L et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obesepatients. European Multicentre Orlistat Study Group Lancet 1998 352: 167\u2013172","journal-title":"Lancet"},{"key":"BF1001297_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/oby.2000.8","volume":"8","author":"S Rossner","year":"2000","unstructured":"Rossner S et al. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European OrlistatObesity Study Group Obes Res 2000 8: 49\u201361","journal-title":"Obes Res"},{"key":"BF1001297_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","volume":"281","author":"MH Davidson","year":"1999","unstructured":"Davidson MH et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial JAMA 1999 281: 235\u2013242","journal-title":"JAMA"},{"key":"BF1001297_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/archfami.9.2.160","volume":"9","author":"J Hauptman","year":"2000","unstructured":"Hauptman J et al. Hauptman Orlistat in the long-term treatment of obesity in primary care settings Arch Fam Med 2000 9: 160\u2013167","journal-title":"Arch Fam Med"},{"key":"BF1001297_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.HYP.14.5.570","volume":"14","author":"J Stamler","year":"1989","unstructured":"Stamler J et al. INTERSALT study findings. Public health and medical care implications Hypertension 1989 14: 570\u2013577","journal-title":"Hypertension"},{"key":"BF1001297_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/bmj.1.5588.352","volume":"1","author":"JF Munro","year":"1968","unstructured":"Munro JF, MacCuish AC, Wilson EM, Duncan LJP . Comparison of continuous and intermittent anorectic therapy in obesity Br Med J 1968 1: 352\u2013356","journal-title":"Br Med J"},{"key":"BF1001297_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","volume":"106","author":"M Apfelbaum","year":"1999","unstructured":"Apfelbaum M et al. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine Am J Med 1999 106: 179\u2013184","journal-title":"Am J Med"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001297","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:26:31Z","timestamp":1647548791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"alternative-id":["BF1001297"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001297","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]},"assertion":[{"value":"1 March 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}